scholarly journals Self-Care Practice Intervention on Quality of Life among Patients with Type Two Diabetes Mellitus

2020 ◽  
Vol 8 (7) ◽  
pp. 949-958
Author(s):  
Dr. Eman Elsayed Hussein
Keyword(s):  
Quality Of Life ◽  
Diabetes Mellitus ◽  
Self Care ◽  
Care Practice ◽  
Type Two Diabetes

scholarly journals The Model of Self Care Behaviour and the Relationship with Quality Of Life, Metabolic Control and Lipid Control of Type 2 Diabetes Mellitus Patients in Binjai City, Indonesia

2018 ◽  
Vol 6 (9) ◽  
pp. 1762-1767 ◽  
Author(s):  
Rina Amelia
Keyword(s):  
Quality Of Life ◽  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Metabolic Control ◽  
Self Care ◽  
The Self ◽  
Lipid Control ◽  
Diabetes Patients

BACKGROUND: Diabetes is a type of chronic disease with exceptional medical care for a patient's lifetime, which ultimately requires lifestyle and behavioural adjustments to prevent complications to death. Patients with good self-care behaviour will cause diabetes to be controlled to avoid complications to death and make patients have a better quality of life. AIM: This study aims (1) to determine the model of self-care behaviour in Type 2 diabetes patients in Binjai City (2) to analyse the effect of self-care behaviour on quality of life, metabolic control and lipid control of Type 2 diabetes patients in Binjai City. METHODS: This type of research is survey-based and explanatory using a cross-sectional approach. The study population was Type 2 Diabetes Mellitus (T2DM) patients who remained patients in 8 primary health centres in Binjai City. The consecutive sampling yielded a sample size of 115 people. Data analysis method uses descriptive statistics and Structural Equation Modeling (SEM) using SPSS and Amos 16.0. RESULTS: The results showed that all factors that build T2DM patient self-care behaviour were able to be predictors that shape the patient's self-care behaviour. The self-care behaviour model consists of knowledge, attitudes, communication, financing, family support, motivation, and self-efficacy. Motivation is the most significant predictor of its contribution to the self-care behaviour of Type 2 diabetes patients. Self-care behaviour was also known to be significantly related to the quality of life, metabolic control and lipid control of T2DM patients (p < 0.05). CONCLUSION: Self-care behaviour in T2DM patients can have a substantial and significant impact on quality of life, metabolic control and lipid control possessed by Type 2 Diabetes patients.

Predictors of Health-related Quality of Life and Self-care in a Large Sample of Spanish Adults with Diabetes Mellitus

2016 ◽  
Vol 17 (8) ◽  
pp. 1-17
Author(s):  
Clara Marcuello ◽  
Carmen Montañez ◽  
Borja Muñoz ◽  
Ester Montenegro ◽  
Isabel Calvo ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Diabetes Mellitus ◽  
Self Care ◽  
Health Related Quality ◽  
Large Sample ◽  
Related Quality ◽  
Health Related

scholarly journals Effect of Self-Care Guidelines on Quality of Life for Patients with Hepatocellular Carcinoma Undergoing Radiofrequency Ablation

2021 ◽  
Vol 3 (3) ◽  
pp. 11
Author(s):  
Azhar T. Zaki ◽  
Manal S. Hassan ◽  
Ahmed H. Soliman ◽  
Yosreah M. Mohamed
Keyword(s):  
Quality Of Life ◽  
Hepatocellular Carcinoma ◽  
Radiofrequency Ablation ◽  
Self Care ◽  
Care Practice ◽  
Total Quality ◽  
Patient Reported ◽  
Care Guidelines ◽  
Care Practices

Context: Hepatocellular carcinoma (HCC) is considered one of the most challenging tumors with high incidence, prevalence, and mortality rates. Radiofrequency Ablation (RFA) is one of the emerging therapeutic modalities used for the minimally invasive treatment in the management of early-stage HCC. Aim: This study aimed to assess the effect of self-care guidelines on quality of life for patients with Hepatocellular Carcinoma undergoing Radio Frequency Ablation. Methods: A quasi-experimental design was used to achieve the aim of this study. This study was conducted at the Interventional Radiology Unit, affiliated to Ain Shams University Hospital, on a purposive sample of 50 patients with hepatocellular carcinoma; 25 randomly allocated to the study group, and 25 allocated to the control group. A structured interview questionnaire for patients with hepatocellular carcinoma undergoing radiofrequency ablation was used to collect the study data. It comprises three parts: Sociodemographic characteristic, assessment of patients' medical health, and knowledge about HCC and RFA. The second tool was the quality of life of cancer survivors questionnaire (pre /posttest), and finally, a patient-reported self-care practices assessment checklist (pre /posttests). Results: There were statistically significant differences between the study and control groups regarding their total knowledge about hepatocellular carcinoma and radiofrequency ablation therapy pre and post-implementation of self-care guidelines. There were highly statistically significant differences between both groups regarding the total quality of life, pre and post-implementation of self-care guidelines. In addition, there were highly statistically significant differences regarding total self-care practice, pre, and post-implementation of self-care guidelines. A positive correlation was revealed between total knowledge with total self-care practice and total quality of life (pre/posttest). Also, a significant correlation was revealed between the total quality of life and self-care practices post self-care guidelines implementation at (p<0.001). Conclusion: Implementation of self-care guidelines were improved patients' knowledge, quality of life, and self-care practices for patients with hepatocellular carcinoma undergoing radiofrequency ablation. A simplified, illustrated, and comprehensive Arabic booklet including self-care guidelines should be available for patients with hepatocellular carcinoma undergoing radiofrequency ablation. Replication of the current study on a larger probability sample is recommended to achieve generalization of the results. Further studies are recommended to assess factors affecting the quality of life for patients with hepatocellular carcinoma undergoing radiofrequency ablation.

scholarly journals Relationship Between Family Support and Self Care Agency with the Quality of Living Type II Diabetes Patients

2019 ◽  
Vol 3 (1) ◽  
pp. 22-32
Author(s):  
Ferawati ◽  
Mei Fitria Kurniati
Keyword(s):  
Quality Of Life ◽  
Diabetes Mellitus ◽  
Family Support ◽  
Type Ii Diabetes ◽  
Self Care ◽  
P Value ◽  
Diabetic Patients ◽  
Type Ii ◽  
Care Agency

Background: Diabetes Mellitus is a chronic disease characterized by high blood sugar level and is caused by an increase in glucose levels due to a progressive decrease in insulin secretion caused by insulin resistance. The ability of diabetic patients to do appropriate and succesful self-care habits is closely related to morbidity and mortality and significantly affect productivity and quality of life. Purpose: The purpose of this study is to determie the correlation between family support and self care agency with quality of life of diabetes mellitus patient type II.Method: This study uses analitycal methods, namely research that explores how and why health phenomena occur with a cross-sectional approach.Result: The results of the Spearman-Rho test that the P-value in te sig (2-tailed) column 0.123 is more than the level of significance α 0,05 ( 0,000 < 0,05 ) so it can be concluded that H0 is accepted and H1 is rejected.Conclusion: There is no relationship between self care agency and the quality of life of people with type II diabetes mellitus in prolanic patients

scholarly journals HUBUNGAN SELF CARE DENGAN KUALITAS HIDUP PASIEN DIABETES MELITUS

2017 ◽  
Vol 2 (2) ◽  
pp. 132
Author(s):  
Reny Chaidir ◽  
Ade Sry Wahyuni ◽  
Deni Wahyu Furkhani
Keyword(s):  
Quality Of Life ◽  
Diabetes Mellitus ◽  
Random Sampling ◽  
Pearson Correlation ◽  
Self Care ◽  
Simple Random Sampling ◽  
Font Size ◽  
Cross Sectional ◽  
Diabetes Melitus

Indonesia merupakan daerah terbanyak nomor dua penderita diabets melitus di kawasan Asia Tenggara dengan angka kejadian sebesar 9,116.03 kasus. Puskesmas Tigo Baleh angka kunjungan penderita diabetes melitus pada tahun 2015 mengalami peningkatan yaitu sebesar 408 kunjungan. Pasien diabetes melitus rentan mengalami komplikasi yang disebabkan oleh peningkatan kadar gula darah. Peningkatan kadar gula darah dapat dicegah dengan melakukan <em style="font-size: 10px;">self care </em><span style="font-size: 10px;">terdiri dari pengaturan diet, olah raga, terapi obat, perawatan kaki, dan pemantauan gula darah. Tujuan penelitian ini adalah untuk mengetahui adanya hubungan </span><em style="font-size: 10px;">self care </em><span style="font-size: 10px;">dengan kualitas hidup pasien diabetes mellitus. Penelitian ini menggunakan pendekatan </span><em style="font-size: 10px;">cross sectional </em><span style="font-size: 10px;">yang dilakukan terhadap 89 orang responden dengan menggunakan teknik </span><em style="font-size: 10px;">simple random sampling</em><span style="font-size: 10px;">. Pengumpulan data menggunakan kuesioner </span><em style="font-size: 10px;">The Summary of Diabetes Self-Care Activities (SDSCA) </em><span style="font-size: 10px;">dan kuesioner </span><em style="font-size: 10px;">The Diabetes Quality of Life Brief Clinical Inventory</em><span style="font-size: 10px;">. Hasil penelitian ini menggunakan uji </span><em style="font-size: 10px;">product moment </em><span style="font-size: 10px;">(</span><em style="font-size: 10px;">pearson correlation</em><span style="font-size: 10px;">), diperoleh nilai r = 0.432. Kesimpulan dari penelitian ini adalah terdapat hubungan antara </span><em style="font-size: 10px;">self care </em><span style="font-size: 10px;">dengan kualitas hidup pasien diabetes melitus di wilayah kerja Puskesmas Tigo Baleh yang berbanding lurus dan memiliki tingkat korelasi yang sedang. Terdapat faktor yang mempengaruhi korelasi dengan kualitas hidup. Diharapkan agar pasien diabetes melitus dapat meningkatkan aktivitas </span><em style="font-size: 10px;">self care </em><span style="font-size: 10px;">sehingga dapat menjalankan kehidupan secara normal.</span>

scholarly journals Association of Self-Care Behaviors and Quality of Life among Patients with Type 2 Diabetes Mellitus: Chaldoran County, Iran

2017 ◽  
Vol 41 (6) ◽  
pp. 449 ◽  
Author(s):  
Towhid Babazadeh ◽  
Mostafa Dianatinasab ◽  
Amin Daemi ◽  
Hossein Ali Nikbakht ◽  
Fatemeh Moradi ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Self Care

scholarly journals Evaluation of Self-Care Activities and Quality of Life in Patients With Type 2 Diabetes Mellitus Treated With Metformin Using the 2D Matrix Code of Outer Drug Packages as Patient Identifier: Protocol for the DePRO Proof-of-Concept Observational Study (Preprint)

2020 ◽  
Author(s):  
Christian Mueller ◽  
Isabel Schauerte ◽  
Stephan Martin
Keyword(s):  
Quality Of Life ◽  
Diabetes Mellitus ◽  
Data Collection ◽  
Treatment Satisfaction ◽  
Self Care ◽  
The Self ◽  
Digital Data ◽  
Psychological State

BACKGROUND Diabetes mellitus (DM) is one of the most common noncommunicable diseases. DM has a substantial negative impact on patients’ quality of life, which is measured using a variety of diabetes-specific measures covering multiple aspects of patients’ psychological state, behavior, and treatment satisfaction. A fully digital data collection system, including patient identification, would represent a substantial advance in how these patient-reported outcome (PRO) data are measured. Within the European Union, one way to identify patients without the involvement of health care professionals is to use the unique 2D matrix codes on the packaging of prescription medication—for example, metformin, the recommended initial treatment for patients with type 2 DM (T2DM). OBJECTIVE In the DePRO study we aim to (1) describe the self-care activities of patients with T2DM using metformin-containing medication; (2) describe the self-reported health status (eg, presence of diabetes complications and quality of life) of these patients; (3) describe associations between self-care activities and demographics and disease characteristics; and (4) assess the usability of the my ePRO app. METHODS DePRO is an observational, multicenter, cross-sectional, digital, patient-driven study conducted in Germany. Patients with a prescription for a metformin-containing medication will be given a postcard by their pharmacist, which will include a download link for the my ePRO app. In total, 12 diabetes-focused pharmacies, selected to represent urban and rural areas, will be recruited. Participants will use their own mobile device (bring your own device) to download the my ePRO app and access the DePRO study, for which they can register using the 2D matrix code on their medication. An electronic informed consent form will be displayed to the patients and only after giving consent will patients be able to complete the study questionnaires. The PRO instruments used in the study are the Summary of Diabetes Self-Care Activities Scale, the Diabetes Treatment Satisfaction Questionnaire, and the 5 level, 5-dimension EuroQol Questionnaire. Patients will also be asked to complete a questionnaire with items addressing demographics, patient characteristics, disease history, complications, and concomitant medications. Data will be transferred to the study database by the app upon completion of each questionnaire. Statistical analyses of primary and secondary endpoints will be exploratory and descriptive. RESULTS Enrollment began in June 2020. The estimated study completion date is December 31, 2020, and the planned sample size is 300 patients. CONCLUSIONS The DePRO study uses completely digital data collection, including authentication of eligible patients and completion of the study questionnaires. Therefore, the design of the DePRO study represents a substantial advance in the evaluation of the digital capturing of PRO data. CLINICALTRIAL ClinicalTrials.gov NCT04383041; https://clinicaltrials.gov/ct2/show/NCT04383041 INTERNATIONAL REGISTERED REPORT PRR1-10.2196/21727

scholarly journals Evaluation of Self-Care Activities and Quality of Life in Patients With Type 2 Diabetes Mellitus Treated With Metformin Using the 2D Matrix Code of Outer Drug Packages as Patient Identifier: Protocol for the DePRO Proof-of-Concept Observational Study

10.2196/21727 ◽  
2021 ◽  
Vol 10 (1) ◽  
pp. e21727
Author(s):  
Christian Mueller ◽  
Isabel Schauerte ◽  
Stephan Martin
Keyword(s):  
Quality Of Life ◽  
Diabetes Mellitus ◽  
Data Collection ◽  
Treatment Satisfaction ◽  
Self Care ◽  
The Self ◽  
Digital Data ◽  
Psychological State

Background Diabetes mellitus (DM) is one of the most common noncommunicable diseases. DM has a substantial negative impact on patients’ quality of life, which is measured using a variety of diabetes-specific measures covering multiple aspects of patients’ psychological state, behavior, and treatment satisfaction. A fully digital data collection system, including patient identification, would represent a substantial advance in how these patient-reported outcome (PRO) data are measured. Within the European Union, one way to identify patients without the involvement of health care professionals is to use the unique 2D matrix codes on the packaging of prescription medication—for example, metformin, the recommended initial treatment for patients with type 2 DM (T2DM). Objective In the DePRO study we aim to (1) describe the self-care activities of patients with T2DM using metformin-containing medication; (2) describe the self-reported health status (eg, presence of diabetes complications and quality of life) of these patients; (3) describe associations between self-care activities and demographics and disease characteristics; and (4) assess the usability of the my ePRO app. Methods DePRO is an observational, multicenter, cross-sectional, digital, patient-driven study conducted in Germany. Patients with a prescription for a metformin-containing medication will be given a postcard by their pharmacist, which will include a download link for the my ePRO app. In total, 12 diabetes-focused pharmacies, selected to represent urban and rural areas, will be recruited. Participants will use their own mobile device (bring your own device) to download the my ePRO app and access the DePRO study, for which they can register using the 2D matrix code on their medication. An electronic informed consent form will be displayed to the patients and only after giving consent will patients be able to complete the study questionnaires. The PRO instruments used in the study are the Summary of Diabetes Self-Care Activities Scale, the Diabetes Treatment Satisfaction Questionnaire, and the 5 level, 5-dimension EuroQol Questionnaire. Patients will also be asked to complete a questionnaire with items addressing demographics, patient characteristics, disease history, complications, and concomitant medications. Data will be transferred to the study database by the app upon completion of each questionnaire. Statistical analyses of primary and secondary endpoints will be exploratory and descriptive. Results Enrollment began in June 2020. The estimated study completion date is December 31, 2020, and the planned sample size is 300 patients. Conclusions The DePRO study uses completely digital data collection, including authentication of eligible patients and completion of the study questionnaires. Therefore, the design of the DePRO study represents a substantial advance in the evaluation of the digital capturing of PRO data. Trial Registration ClinicalTrials.gov NCT04383041; https://clinicaltrials.gov/ct2/show/NCT04383041 International Registered Report Identifier (IRRID) PRR1-10.2196/21727

Sign in / Sign up

Export Citation Format

Share Document